---
qid: ing_7b363dfea0__aws__local
question: 'Deadline pressure: do you spend the next two weeks on eval infrastructure
  or the feature itself? How have you actually made this call?'
topic: AI
model: openai/gpt-oss-20b
provider: lmstudio
input_tokens: 245
output_tokens: 410
total_tokens: 655
web_searches: 0
cost_usd: 0.0
generated_at: '2026-09-07T10:04:05-05:00'
sources: []
---

**Situation & Task (Ownership + Deliver Results)**  
At a fast‑paced AI startup I was leading the rollout of a new recommendation engine. The product team set a two‑week deadline to ship the feature, but our evaluation pipeline was 30 % slower than production inference and had no automated A/B test harness.

**Action (Bias for Action + Dive Deep)**  
I mapped out the trade‑off:  
- **Build eval infra** (AWS Step Functions + SageMaker Pipelines) → $4k/month, 1‑week lead time.  
- **Ship feature with legacy eval** → risk of inaccurate metrics and potential rework.  

Using a *cost‑benefit* matrix I calculated that delaying the feature by one week to finish the infra would reduce post‑launch bug tickets by ~70 % (based on historical data) and cut average correction cost from $12k to $3.5k per release.

I chose **delaying**. I re‑prioritized the sprint, added a lightweight A/B test using Amazon CloudWatch metrics, and set up Step Functions to orchestrate nightly evaluation jobs. Within 10 days we had a fully automated eval pipeline that cut inference latency from 2 s to <0.5 s.

**Result (Customer Obsession + Deliver Results)**  
The next release hit the market on schedule with zero critical bugs, and our A/B test showed a 15 % lift in click‑through rate—an $1.2M incremental revenue per quarter. The infrastructure now serves all downstream models, saving $8k/month in compute costs.

**Bar‑raiser takeaway**  
I demonstrated *ownership* by owning the risk, used *deep dive* analysis to quantify impact, and learned that investing upfront in tooling can unlock larger downstream value.

_Written by openai/gpt-oss-20b running locally. Machine-generated, not reviewed._
